DeepX Health

DeepX Health is a health care startup based in the United States, founded in 2019. The company's mission is encapsulated in its slogan, "We improve patient care and save lives." DeepX Health specializes in skin cancer teledermatology and diagnostics, aiming to facilitate early diagnosis through the convergence of device technology, AI, and teledermatology. Their flagship product, DermoSight, is a dermatoscope tailored for skin cancer scanning and is poised for future integration with an AI diagnostics algorithm, underpinned by proprietary Optical Transfer Diagnosis (OTD) technology. The absence of specific details regarding last investment and last investment investors signifies that there's no recent publicly disclosed funding round. While the potential of their innovative technology is evident, the lack of recent investment disclosures may raise questions about the current financial standing and tailored growth strategies. However, the company's profound dedication to revolutionizing patient care in the realm of dermatology, coupled with their pioneering approach to diagnostic technologies, positions DeepX Health as a compelling prospect for potential investors seeking to penetrate the burgeoning digital health market.